[go: up one dir, main page]

BRPI0517479A - nutrição contendo mistura de gorduras - Google Patents

nutrição contendo mistura de gorduras

Info

Publication number
BRPI0517479A
BRPI0517479A BRPI0517479-1A BRPI0517479A BRPI0517479A BR PI0517479 A BRPI0517479 A BR PI0517479A BR PI0517479 A BRPI0517479 A BR PI0517479A BR PI0517479 A BRPI0517479 A BR PI0517479A
Authority
BR
Brazil
Prior art keywords
lipid
total weight
acid
dpan
dha
Prior art date
Application number
BRPI0517479-1A
Other languages
English (en)
Inventor
Bernd Stahl
Guenther Boehm
Christopher Beermann
Johan Garssen
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34927339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0517479(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BRPI0517479A publication Critical patent/BRPI0517479A/pt
Publication of BRPI0517479B1 publication Critical patent/BRPI0517479B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Fats And Perfumes (AREA)
  • Dairy Products (AREA)
  • Medicinal Preparation (AREA)

Abstract

NUTRIçãO CONTENDO MISTURA DE GORDURAS. A presente invenção refere-se ao uso de ácidos graxos poilinsaturados de cadeia longa para a fabricação de uma composição nutricional para a alimentação de bebés de mães que tenham sofrido de um distúrbio metabólico durante a gravidez e a uma composição correspondente. A dita composição compreende uma fração de ácidos graxos poliinsaturados n-3 contendo pelo menos 0,1% em peso de ácido docosahexaenóico (DHA), com base no peso total de lipídios, pelo menos 0,01% em peso de ácido docosapentaenóico n-3 (DPAn-3), com base no peso total de lipídios, e pelo menos 0,01% em peso de ácido eicosapentaenóico (EPA), com base no peso total de lipídios, em que a soma de DHA, DPAn-3 e EPA está abaixo de 1 % em peso dos lipídios totais.
BRPI0517479-1A 2004-11-11 2005-11-11 Uso de ácidos graxos poliinsaturados de cadeia longa e composição nutricional BRPI0517479B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04026825A EP1656839A1 (en) 2004-11-11 2004-11-11 Nutrition containing lipid blend
EP04026825.2 2004-11-11
PCT/EP2005/012122 WO2006050975A1 (en) 2004-11-11 2005-11-11 Nutrition containing fat blend

Publications (2)

Publication Number Publication Date
BRPI0517479A true BRPI0517479A (pt) 2008-10-07
BRPI0517479B1 BRPI0517479B1 (pt) 2015-06-09

Family

ID=34927339

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517479-1A BRPI0517479B1 (pt) 2004-11-11 2005-11-11 Uso de ácidos graxos poliinsaturados de cadeia longa e composição nutricional

Country Status (18)

Country Link
US (2) US8053471B2 (pt)
EP (3) EP1656839A1 (pt)
JP (1) JP2008519796A (pt)
CN (2) CN101052316B (pt)
AT (1) ATE457656T1 (pt)
AU (1) AU2005303903B2 (pt)
BR (1) BRPI0517479B1 (pt)
CA (1) CA2586946C (pt)
DE (1) DE602005019452D1 (pt)
DK (1) DK1809125T3 (pt)
ES (1) ES2341355T3 (pt)
NZ (1) NZ554629A (pt)
PL (1) PL1809125T3 (pt)
PT (1) PT1809125E (pt)
RU (1) RU2402927C2 (pt)
SG (1) SG143274A1 (pt)
UA (1) UA89207C2 (pt)
WO (1) WO2006050975A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
US10086009B2 (en) 2005-05-23 2018-10-02 Massachusetts Institute Of Technologies Compositions containing pufa and/or uridine and methods of use thereof
WO2007058523A1 (en) * 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
CA2634693A1 (en) * 2005-12-23 2007-06-28 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition
WO2008054193A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Nutritional products that comprise saccharide oligomers
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
CA2692309C (en) 2007-06-26 2016-08-16 N.V. Nutricia Improving memory in subjects with mini-mental state examination of 24-26
WO2009002146A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
CN100542411C (zh) * 2007-09-24 2009-09-23 张国浩 一种含ω-3多不饱和脂肪酸的营养均衡调和油及其生产方法
ES2411726T3 (es) 2007-12-20 2013-07-08 N.V. Nutricia Producto líquido que contiene nucleótidos/nucleósidos
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US9149452B2 (en) * 2009-04-20 2015-10-06 Women's & Children's Health Research Institute Inc. Methods and compositions for promoting the neurological development of an infant
JP5335601B2 (ja) * 2009-07-30 2013-11-06 ビーンスターク・スノー株式会社 栄養組成物
WO2012087113A1 (en) * 2010-12-24 2012-06-28 N.V. Nutricia Improved nutritional tablet
SG11201403712XA (en) * 2011-12-27 2014-10-30 Abbott Lab Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life
CA2916208A1 (en) 2012-06-17 2013-12-27 Matinas Biopharma, Inc. Omega-3 pentaenoic acid compositions and methods of use
CA2905671A1 (en) * 2013-03-13 2014-09-18 Matinas Biopharma Inc. Omega-3 pentaenoic acid compositions and methods of use
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
FR3045069B1 (fr) * 2015-12-14 2019-01-25 Metabolium Procede d'enrichissement de protistes en lipides riches en acides gras polyinsatures, plus particulierement de classe omega 3, et sa mise en oeuvre pour la production de ces lipides
CN109310662A (zh) * 2016-04-18 2019-02-05 N·V·努特里奇亚 用于减少生命早期应激诱导的认知下降/神经发生减少的亚油酸和α-亚麻酸
JP2020531589A (ja) * 2017-08-25 2020-11-05 ストラクト・ニュートリション・エルエルシー 頭部外傷後の神経損傷を予防、軽減、及び治療するための組成及び方法
WO2021092209A1 (en) * 2019-11-08 2021-05-14 Abbott Laboratories Bovine milk-isolated powdered exosomes, nutritional compositions and methods
WO2023232882A1 (en) 2022-05-31 2023-12-07 N.V. Nutricia Infant formula for improving cognitive development

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
KR940003473A (ko) 1992-08-14 1994-03-12 이순목 n-3 지방산이 축적된 우유 및 우유용 사료조성물
NL9401644A (nl) * 1994-10-06 1996-05-01 Friesland Brands Bv Voedingsmiddel voor zwangere en lacterende vrouwen
DE69637953D1 (de) * 1995-04-17 2009-07-30 Nat Inst Of Advanced Ind Scien Hoch ungesättigte fettsäurenproduzierende mikroorganismen und verfahren zur herstellung von hoch ungesättigten fettsäuren durch verwendung dieser mikroorganismen
US6432468B1 (en) * 1995-05-30 2002-08-13 Suntory Limited Domestic fowl eggs having a high content of highly unsaturated fatty acid, their production process and their use
DE69622722T2 (de) * 1996-11-20 2003-02-27 N.V. Nutricia, Zoetermeer Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselsyndroms
PL343902A1 (en) * 1997-02-21 2001-09-10 Abbott Lab Methods of and compositions for reducing enteritis and colitis morbidity rate
CN1660065A (zh) * 1997-03-27 2005-08-31 布里斯托尔-迈尔斯斯奎布公司 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途
US6432684B1 (en) * 1997-04-11 2002-08-13 Abbott Laboratories Human desaturase gene and uses thereof
DK0893064T3 (da) * 1997-07-22 2003-04-22 Nestle Sa Lipidsammensætning til præparater til spædbørn samt fremstillingsfremgangsmåde for denne
AU6503699A (en) * 1998-10-05 2000-04-26 Abbott Laboratories Altered fatty acid biosynthesis in insect cells using delta five desaturase
US6596302B2 (en) * 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
ITBO20000471A1 (it) 2000-07-31 2002-01-31 Vieri Ridolfi Dispositivo di supporto per prodotti da fumo particolarmente sigarette .
DE10057976B4 (de) 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
CA2451116C (en) * 2001-05-14 2013-04-09 Martek Biosciences Corporation Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
US20040209953A1 (en) * 2002-12-06 2004-10-21 Wai Lee Theresa Siu-Ling Glyceride compositions and methods of making and using same
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend

Also Published As

Publication number Publication date
JP2008519796A (ja) 2008-06-12
EP1809125A1 (en) 2007-07-25
EP2191733A1 (en) 2010-06-02
CN102511818B (zh) 2014-12-24
SG143274A1 (en) 2008-06-27
EP1656839A1 (en) 2006-05-17
AU2005303903B2 (en) 2012-05-31
DE602005019452D1 (de) 2010-04-01
US20120027885A1 (en) 2012-02-02
US20080269330A1 (en) 2008-10-30
US8729123B2 (en) 2014-05-20
ATE457656T1 (de) 2010-03-15
AU2005303903A1 (en) 2006-05-18
CA2586946C (en) 2014-09-30
ES2341355T3 (es) 2010-06-18
UA89207C2 (ru) 2010-01-11
RU2402927C2 (ru) 2010-11-10
CN102511818A (zh) 2012-06-27
WO2006050975A1 (en) 2006-05-18
BRPI0517479B1 (pt) 2015-06-09
RU2007121665A (ru) 2008-12-20
CA2586946A1 (en) 2006-05-18
CN101052316A (zh) 2007-10-10
DK1809125T3 (da) 2010-06-07
EP1809125B1 (en) 2010-02-17
CN101052316B (zh) 2012-02-22
NZ554629A (en) 2010-09-30
PT1809125E (pt) 2010-05-20
PL1809125T3 (pl) 2010-07-30
US8053471B2 (en) 2011-11-08

Similar Documents

Publication Publication Date Title
BRPI0517479A (pt) nutrição contendo mistura de gorduras
Scollan et al. Innovations in beef production systems that enhance the nutritional and health value of beef lipids and their relationship with meat quality
Moriguchi et al. Effects of an n-3-deficient diet on brain, retina, and liver fatty acyl composition in artificially reared rats
PL1781307T3 (pl) Immunostymulująca odżywka dla niemowląt
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
JP2008519796A5 (pt)
NO942365L (no) Lipidisk sammensetning for anvendelse som et næringsmiddel eller i næringsmiddelprodukter
JP2006501840A5 (pt)
DK1121115T4 (da) PUFA-tilskud
DK1155620T3 (da) Kosttilskudsmiddel med vitaminer, mineraler og flerumættede fedtsyrer
RU2013146517A (ru) Композиции и способы, пригодные для облегчения возрастных заболеваний
CO5550401A2 (es) Mezclas lipidas y productos alimenticios que contienen acido graso oleico y acidos grasos omega-6 diseñados para aumentar el nivel de lipido intramiocelular
Kennedy et al. Influence of dietary conjugated linoleic acid (CLA) on lipid and fatty acid composition in liver and flesh of Atlantic salmon (Salmo salar)
Wadhwani et al. Effect of maternal micronutrients (folic acid, vitamin B12) and omega 3 fatty acids on liver fatty acid desaturases and transport proteins in Wistar rats
DK1027831T3 (da) Stabiliseret fedtstofsammensætning, fremgangsmåde til fremstilling deraf og ernæringsprodukt indeholdende denne
Minihane et al. Health benefits of polyunsaturated fatty acids (PUFAs)
EP0437524A1 (en) TRIGLYCERIDES AND NUTRITIONAL COMPOSITION COMPRISING THE SAME.
Gillingham The metabolic fate of alpha linolenic acid (ALA)
Dangat et al. Maternal supplementation of omega 3 fatty acids to micronutrient-imbalanced diet improves lactation in rat
Vaezi Efficacy and Biomedical Roles of Unsaturated Fatty Acids as Bioactive Food Components
Hassam The influence of α-linolenic acid (18: 3ω3) on the metabolism of γ-linolenic acid (18: 3ω6) in the rat
Delplanque et al. Brain docosahexaenoic acid (DHA) levels of young rats are related to alpha-linolenic acid (ALA) levels and fat matrix of the diet: impact of dairy fat
Idris et al. Effects of Chemically Interesterified Palm Olein on Lipid Profiles in Hamsters.
Bauer New insights and existing perceptions of fish oil omega-3 fatty acids in companion animal clinical practice.
Patten et al. Dietary fish oil supplementation increases the in vitro contractility of rat ileum

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/11/2005, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A23L 1/29; A23L 1/30; A23L 1/308; A61K 31/02; A61P 3/02.

Ipc: A61K 31/202 (2006.01), A23L 33/12 (2016.01), A23L

Ipc: A61K 31/202 (2006.01), A23L 33/12 (2016.01), A23L

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2487 DE 04-09-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.